Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Prevention of Postoperative AKI in Aortic Surgery
NCT02157337Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Mar 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atorvastatin in acute kidney injury (AKI) (2 arms), sponsored by Yonsei University. Primary endpoint: Incidence of Acute Kidney Injury (Stage 1) at 7 days. Started Mar 2014; status: completed.
02
Drugs
atorvastatin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02157337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02157337.